R1 RCM Inc. (RCM)
14.31
null (null%)
At close: Nov 18, 2024, 9:00 PM
undefined% (1D)
| Bid | n/a |
| Market Cap | 6.04B |
| Revenue (ttm) | 2.46B |
| Net Income (ttm) | -61.2M |
| EPS (ttm) | -0.14 |
| PE Ratio (ttm) | -102.21428571428571 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | n/a |
| Volume | 0 |
| Avg. Volume (20D) | 0 |
| Open | undefined |
| Previous Close | undefined |
| Day's Range | 14.31 - 14.31 |
| 52-Week Range | 14.31 - 14.31 |
| Beta | 0.84 |
About RCM
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with...
Sector Healthcare
IPO Date Mar 16, 2017
Employees 29,400
Stock Exchange NASDAQ
Ticker Symbol RCM
Website https://www.r1rcm.com
Analyst Forecast
According to 9 analyst ratings, the average rating for RCM stock is "Hold." The 12-month stock price forecast is $15, which is an increase of 4.82% from the latest price.
Stock ForecastsNext Earnings Release
R1 RCM Inc. is scheduled to release its earnings on May 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
8 months ago
+9.7%
R1 RCM shares are trading higher after the company...
Unlock content with
Pro Subscription
9 months ago
+15.62%
R1 RCM shares are trading higher after Morgan Stanley maintained an Overweight rating and a $17 price target. The stock fell last week after the company announced New Mountain Capital is no longer interested in pursuing a joint proposal with TCP-ASC.
